Related Experiment Video
Updated: May 7, 2026
08:25
Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma
Published on: April 25, 2025
Identification of biomarkers for hepatocellular carcinoma using network-based bioinformatics methods
Lingyan Zhang1, Ying Guo, Bibo Li
1Department of Radiology, College of Basic Medicine, Chongqing Medical University, No,1 Yixueyuan Road, Yuzhong District, Chongqing 400016, P,R, China. lishaolin@cqmu.edu.cn.
European Journal of Medical Research
|October 3, 2013
Summary
This study identifies key genes and pathways involved in hepatocellular carcinoma (HCC) using bioinformatics. These findings offer potential biomarkers for early HCC diagnosis and therapeutic targets.
Area of Science:
- Oncology
- Bioinformatics
- Molecular Biology
Background:
- Hepatocellular carcinoma (HCC) is a prevalent global cancer.
- The molecular mechanisms underlying HCC remain incompletely understood.
- There is a need for novel biomarkers for early HCC detection.
Purpose of the Study:
- To investigate the molecular mechanisms of HCC.
- To identify potential biomarkers for early HCC diagnosis.
- To analyze gene expression profiles in HCC.
Main Methods:
- Utilized Gene Expression Omnibus (GEO) data for HCC and non-cancerous liver controls.
- Employed a combined bioinformatics approach for data analysis.
- Constructed a protein-protein interaction (PPI) network.
Main Results:
- Identified dysregulated pathways and a PPI network distinguishing HCC from controls.
- 29 differentially expressed genes were found to be phenotype-related and included in the PPI network.
- CDC2, MMP2, and DCN emerged as crucial hub nodes in the PPI network.
Conclusions:
- The study provides a set of potential molecular targets for further HCC research.
- Experimental validation is recommended to confirm the identified biomarkers and targets.
- Findings contribute to a better understanding of HCC molecular pathology.
